Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Cell ; 162(5): 1127-39, 2015 Aug 27.
Article in English | MEDLINE | ID: mdl-26279190

ABSTRACT

The peripheral nervous system has remarkable regenerative capacities in that it can repair a fully cut nerve. This requires Schwann cells to migrate collectively to guide regrowing axons across a 'bridge' of new tissue, which forms to reconnect a severed nerve. Here we show that blood vessels direct the migrating cords of Schwann cells. This multicellular process is initiated by hypoxia, selectively sensed by macrophages within the bridge, which via VEGF-A secretion induce a polarized vasculature that relieves the hypoxia. Schwann cells then use the blood vessels as "tracks" to cross the bridge taking regrowing axons with them. Importantly, disrupting the organization of the newly formed blood vessels in vivo, either by inhibiting the angiogenic signal or by re-orienting them, compromises Schwann cell directionality resulting in defective nerve repair. This study provides important insights into how the choreography of multiple cell-types is required for the regeneration of an adult tissue.


Subject(s)
Blood Vessels/metabolism , Macrophages/metabolism , Peripheral Nerves/physiology , Schwann Cells/metabolism , Animals , Axons/metabolism , Cell Hypoxia , Endothelial Cells/metabolism , Inflammation/metabolism , Male , Mice , Neovascularization, Physiologic , Rats , Rats, Sprague-Dawley , Regeneration , Vascular Endothelial Growth Factor A/genetics
2.
Int J Mol Sci ; 23(3)2022 Jan 26.
Article in English | MEDLINE | ID: mdl-35163321

ABSTRACT

Cannabis is one of the most commonly used recreational drugs worldwide. Rrecent epidemiology studies have linked increased cardiac complications to cannabis use. However, this literature is predominantly based on case incidents and post-mortem investigations. This study elucidates the molecular mechanism of Δ9-tetrahydrocannabinol (THC), and its primary metabolites 11-Hydroxy-Δ9-THC (THC-OH) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH). Treatment of cardiac myocytes with THC-OH and THC-COOH increased cell migration and proliferation (p < 0.05), with no effect on cell adhesion, with higher doses (250-100 ng/mL) resulting in increased cell death and significant deterioration in cellular architecture. Conversely, no changes in cell morphology or viability were observed in response to THC. Expression of key ECM proteins α-SMA and collagen were up-regulated in response to THC-OH and THC-COOH treatments with concomitant modulation of PI3K and MAPK signalling. Investigations in the planarian animal model Polycelis nigra demonstrated that treatments with cannabinoid metabolites resulted in increased protein deposition at transection sites while higher doses resulted in significant lethality and decline in regeneration. These results highlight that the key metabolites of cannabis elicit toxic effects independent of the parent and psychoactive compound, with implications for cardiotoxicity relating to hypertrophy and fibrogenesis.


Subject(s)
Cannabis , Hallucinogens , Analgesics/metabolism , Animals , Cannabinoid Receptor Agonists , Cannabis/metabolism , Cannabis/toxicity , Cardiotoxicity , Dronabinol/toxicity , Hallucinogens/metabolism , Myocytes, Cardiac/metabolism
3.
Hum Mol Genet ; 26(2): 305-319, 2017 01 15.
Article in English | MEDLINE | ID: mdl-28065882

ABSTRACT

Protein misfolding caused by inherited mutations leads to loss of protein function and potentially toxic 'gain of function', such as the dominant P23H rhodopsin mutation that causes retinitis pigmentosa (RP). Here, we tested whether the AMPK activator metformin could affect the P23H rhodopsin synthesis and folding. In cell models, metformin treatment improved P23H rhodopsin folding and traffic. In animal models of P23H RP, metformin treatment successfully enhanced P23H traffic to the rod outer segment, but this led to reduced photoreceptor function and increased photoreceptor cell death. The metformin-rescued P23H rhodopsin was still intrinsically unstable and led to increased structural instability of the rod outer segments. These data suggest that improving the traffic of misfolding rhodopsin mutants is unlikely to be a practical therapy, because of their intrinsic instability and long half-life in the outer segment, but also highlights the potential of altering translation through AMPK to improve protein function in other protein misfolding diseases.


Subject(s)
AMP-Activated Protein Kinases/genetics , Metformin/administration & dosage , Retinal Degeneration/genetics , Retinitis Pigmentosa/genetics , Rhodopsin/genetics , AMP-Activated Protein Kinases/biosynthesis , Animals , Disease Models, Animal , Humans , Mice , Mutant Proteins/genetics , Photoreceptor Cells/drug effects , Photoreceptor Cells/pathology , Protein Folding/drug effects , Proteostasis Deficiencies/genetics , Proteostasis Deficiencies/pathology , Rats , Retinal Degeneration/drug therapy , Retinal Degeneration/pathology , Retinal Rod Photoreceptor Cells/drug effects , Retinal Rod Photoreceptor Cells/metabolism , Retinal Rod Photoreceptor Cells/pathology , Retinitis Pigmentosa/drug therapy , Retinitis Pigmentosa/pathology , Rhodopsin/chemistry , Rod Cell Outer Segment/drug effects , Rod Cell Outer Segment/pathology , Transcriptional Activation/drug effects
4.
Proc Natl Acad Sci U S A ; 112(19): 6086-91, 2015 May 12.
Article in English | MEDLINE | ID: mdl-25922531

ABSTRACT

Jaw morphogenesis depends on the growth of Meckel's cartilage during embryogenesis. However, the cell types and signals that promote chondrocyte proliferation for Meckel's cartilage growth are poorly defined. Here we show that neural crest cells (NCCs) and their derivatives provide an essential source of the vascular endothelial growth factor (VEGF) to enhance jaw vascularization and stabilize the major mandibular artery. We further show in two independent mouse models that blood vessels promote Meckel's cartilage extension. Coculture experiments of arterial tissue with NCCs or chondrocytes demonstrated that NCC-derived VEGF promotes blood vessel growth and that blood vessels secrete factors to instruct chondrocyte proliferation. Computed tomography and X-ray scans of patients with hemifacial microsomia also showed that jaw hypoplasia correlates with mandibular artery dysgenesis. We conclude that cranial NCCs and their derivatives provide an essential source of VEGF to support blood vessel growth in the developing jaw, which in turn is essential for normal chondrocyte proliferation, and therefore jaw extension.


Subject(s)
Goldenhar Syndrome/physiopathology , Mandible/abnormalities , Mandible/embryology , Neural Crest/metabolism , Vascular Endothelial Growth Factor A/metabolism , Adolescent , Animals , Cartilage/embryology , Cell Differentiation , Cell Proliferation , Chondrocytes/metabolism , Coculture Techniques , Female , Goldenhar Syndrome/diagnostic imaging , Humans , In Situ Hybridization , Male , Mandible/blood supply , Mice , Neural Crest/cytology , Tomography, X-Ray Computed , Wnt1 Protein/genetics
5.
Development ; 139(8): 1371-80, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22434866

ABSTRACT

Vascular endothelial growth factor A (VEGF-A) is best known for its essential roles in blood vessel growth. However, evidence has emerged that VEGF-A also promotes a wide range of neuronal functions, both in vitro and in vivo, including neurogenesis, neuronal migration, neuronal survival and axon guidance. Recent studies have employed mouse models to distinguish the direct effects of VEGF on neurons from its indirect, vessel-mediated effects. Ultimately, refining our knowledge of VEGF signalling pathways in neurons should help us to understand how the current use of therapeutics targeting the VEGF pathway in cancer and eye disease might be expanded to promote neuronal health and nerve repair.


Subject(s)
Gene Expression Regulation, Developmental , Nervous System/metabolism , Vascular Endothelial Growth Factor A/physiology , Animals , Axons/metabolism , Brain/embryology , Cell Movement , Cell Survival , Humans , Neoplasms/metabolism , Neovascularization, Pathologic , Nervous System/embryology , Neurons/metabolism , Protein Isoforms , Signal Transduction
6.
Hum Mol Genet ; 18(19): 3553-66, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19578180

ABSTRACT

Following a screen for neuromuscular mouse mutants, we identified ostes, a novel N-ethyl N-nitrosourea-induced mouse mutant with muscle atrophy. Genetic and biochemical evidence shows that upregulation of the novel, uncharacterized transient receptor potential polycystic (TRPP) channel PKD1L2 (polycystic kidney disease gene 1-like 2) underlies this disease. Ostes mice suffer from chronic neuromuscular impairments including neuromuscular junction degeneration, polyneuronal innervation and myopathy. Ectopic expression of PKD1L2 in transgenic mice reproduced the ostes myopathic changes and, indeed, caused severe muscle atrophy in Tg(Pkd1l2)/Tg(Pkd1l2) mice. Moreover, double-heterozygous mice (ostes/+, Tg(Pkd1l2)/0) suffer from myopathic changes more profound than each heterozygote, indicating positive correlation between PKD1L2 levels and disease severity. We show that, in vivo, PKD1L2 primarily associates with endogenous fatty acid synthase in normal skeletal muscle, and these proteins co-localize to costameric regions of the muscle fibre. In diseased ostes/ostes muscle, both proteins are upregulated, and ostes/ostes mice show signs of abnormal lipid metabolism. This work shows the first role for a TRPP channel in neuromuscular integrity and disease.


Subject(s)
Neuromuscular Diseases/metabolism , Receptors, G-Protein-Coupled/metabolism , Up-Regulation , Animals , Cells, Cultured , Disease Models, Animal , Fatty Acid Synthases/genetics , Fatty Acid Synthases/metabolism , Female , HeLa Cells , Humans , Infant , Male , Mice , Mice, Transgenic , Muscle, Skeletal/metabolism , Mutation , Neuromuscular Diseases/genetics , Protein Binding , Receptors, G-Protein-Coupled/genetics
7.
Cells ; 10(11)2021 11 12.
Article in English | MEDLINE | ID: mdl-34831369

ABSTRACT

The activation of microglia, the inflammatory cells of the central nervous system (CNS), has been linked to the pathogenesis of Alzheimer's disease and other neurodegenerative diseases. How microglia sense the changing brain environment, in order to respond appropriately, is still being elucidated. Microglia are able to sense and respond to the mechanical properties of their microenvironment, and the physical and molecular pathways underlying this mechanosensing/mechanotransduction in microglia have recently been investigated. The Hippo pathway functions through mechanosensing and subsequent protein kinase cascades, and is critical for neuronal development and many other cellular processes. In this review, we examine evidence for the potential involvement of Hippo pathway components specifically in microglia in the pathogenesis of Alzheimer's disease. We suggest that the Hippo pathway is worth investigating as a mechanosensing pathway in microglia, and could be one potential therapeutic target pathway for preventing microglial-induced neurodegeneration in AD.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Hippo Signaling Pathway , Mechanotransduction, Cellular , Microglia/metabolism , Microglia/pathology , Animals , Humans , Models, Biological
8.
Mol Cell Neurosci ; 42(4): 296-307, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19683573

ABSTRACT

We used live imaging by fiber-optic confocal microendoscopy (CME) of yellow fluorescent protein (YFP) expression in motor neurons to observe and monitor axonal and neuromuscular synaptic phenotypes in mutant mice. First, we visualized slow degeneration of axons and motor nerve terminals at neuromuscular junctions following sciatic nerve injury in Wld(S) mice with slow Wallerian degeneration. Protection of axotomized motor nerve terminals was much weaker in Wld(S) heterozygotes than in homozygotes. We then induced covert modifiers of axonal and synaptic degeneration in heterozygous Wld(S) mice, by N-ethyl-N-nitrosourea (ENU) mutagenesis, and used CME to identify candidate mutants that either enhanced or suppressed axonal or synaptic degeneration. From 219 of the F1 progeny of ENU-mutagenized BALB/c mice and thy1.2-YFP16/Wld(S) mice, CME revealed six phenodeviants with suppression of synaptic degeneration. Inheritance of synaptic protection was confirmed in three of these founders, with evidence of Mendelian inheritance of a dominant mutation in one of them (designated CEMOP_S5). We next applied CME repeatedly to living Wld(S) mice and to SOD1(G93A) mice, an animal model of motor neuron disease, and observed degeneration of identified neuromuscular synapses over a 1-4day period in both of these mutant lines. Finally, we used CME to observe slow axonal regeneration in the ENU-mutant ostes mouse strain. The data show that CME can be used to monitor covert axonal and neuromuscular synaptic pathology and, when combined with mutagenesis, to identify genetic modifiers of its progression in vivo.


Subject(s)
Axons/ultrastructure , Endoscopy/methods , Fiber Optic Technology/methods , Microscopy, Confocal/methods , Nerve Tissue Proteins/metabolism , Neuromuscular Junction/ultrastructure , Superoxide Dismutase/metabolism , Animals , Axons/pathology , Axons/physiology , Disease Models, Animal , Female , Fiber Optic Technology/instrumentation , Humans , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Mutant Strains , Mice, Transgenic , Microscopy, Confocal/instrumentation , Motor Neuron Disease/genetics , Motor Neuron Disease/metabolism , Motor Neuron Disease/pathology , Motor Neurons/cytology , Motor Neurons/metabolism , Mutation , Nerve Regeneration/physiology , Nerve Tissue Proteins/genetics , Neuromuscular Junction/pathology , Neuromuscular Junction/physiology , Phenotype , Superoxide Dismutase/genetics , Synapses/pathology , Synapses/physiology , Synapses/ultrastructure , Wallerian Degeneration/metabolism , Wallerian Degeneration/pathology
9.
Cells ; 9(1)2020 01 08.
Article in English | MEDLINE | ID: mdl-31936297

ABSTRACT

In order to ascertain their external environment, cells and tissues have the capability to sense and process a variety of stresses, including stretching and compression forces. These mechanical forces, as experienced by cells and tissues, are then converted into biochemical signals within the cell, leading to a number of cellular mechanisms being activated, including proliferation, differentiation and migration. If the conversion of mechanical cues into biochemical signals is perturbed in any way, then this can be potentially implicated in chronic disease development and processes such as neurological disorders, cancer and obesity. This review will focus on how the interplay between mechanotransduction, cellular structure, metabolism and signalling cascades led by the Hippo-YAP/TAZ axis can lead to a number of chronic diseases and suggest how we can target various pathways in order to design therapeutic targets for these debilitating diseases and conditions.


Subject(s)
Cell Cycle Proteins/metabolism , Chronic Disease/epidemiology , Mechanotransduction, Cellular , Protein Serine-Threonine Kinases/metabolism , Transcription Factors/metabolism , Acyltransferases , Hippo Signaling Pathway , Humans , Signal Transduction
10.
PLoS Genet ; 2(10): e149, 2006 Oct 06.
Article in English | MEDLINE | ID: mdl-17029558

ABSTRACT

Otitis media (OM), inflammation of the middle ear, remains the most common cause of hearing impairment in children. It is also the most common cause of surgery in children in the developed world. There is evidence from studies of the human population and mouse models that there is a significant genetic component predisposing to OM, yet nothing is known about the underlying genetic pathways involved in humans. We identified an N-ethyl-N-nitrosourea-induced dominant mouse mutant Junbo with hearing loss due to chronic suppurative OM and otorrhea. This develops from acute OM that arises spontaneously in the postnatal period, with the age of onset and early severity dependent on the microbiological status of the mice and their air quality. We have identified the causal mutation, a missense change in the C-terminal zinc finger region of the transcription factor Evi1. This protein is expressed in middle ear basal epithelial cells, fibroblasts, and neutrophil leukocytes at postnatal day 13 and 21 when inflammatory changes are underway. The identification and characterization of the Junbo mutant elaborates a novel role for Evi1 in mammalian disease and implicates a new pathway in genetic predisposition to OM.


Subject(s)
DNA-Binding Proteins/genetics , Genetic Predisposition to Disease/genetics , Mutation/genetics , Otitis Media/genetics , Proto-Oncogenes/genetics , Transcription Factors/genetics , Amino Acid Sequence , Animals , Chromosome Mapping , Cloning, Molecular , DNA Mutational Analysis , DNA-Binding Proteins/chemistry , Ear, Middle/cytology , Ear, Middle/pathology , Flow Cytometry , Granulocytes/immunology , Lung/cytology , Lung/pathology , MDS1 and EVI1 Complex Locus Protein , Male , Mice , Mice, Inbred BALB C , Mice, Mutant Strains , Molecular Sequence Data , Nose/cytology , Nose/pathology , Otitis Media/immunology , Phenotype , Specific Pathogen-Free Organisms , Transcription Factors/chemistry
11.
Cell Adh Migr ; 6(6): 541-6, 2012.
Article in English | MEDLINE | ID: mdl-23076132

ABSTRACT

Synapse formation, maintenance and plasticity are critical for the correct function of the nervous system and its target organs. During development, these processes enable the establishment of appropriate neural circuits. During adulthood, they allow adaptation to both physiological and environmental changes. In this review, we discuss emerging roles for two families of classical axon and vascular guidance cues in synaptogenesis and synaptic plasticity, the semaphorins and the vascular endothelial growth factors (VEGFs). Their contribution to synapse formation and function add a new facet to the spectrum of overlapping and complementary roles for these molecules in development, adulthood and disease.


Subject(s)
Motor Neurons/physiology , Neuronal Plasticity , Semaphorin-3A/metabolism , Synapses/metabolism , Vascular Endothelial Growth Factor A/metabolism , Animals , Calcium Signaling , Cells, Cultured , Excitatory Postsynaptic Potentials , Hippocampus/metabolism , Hippocampus/physiology , Mice , Motor Neurons/metabolism , Neurogenesis , Semaphorin-3A/genetics , Synapses/physiology , Synaptic Transmission , Vascular Endothelial Growth Factor Receptor-1/genetics , Vascular Endothelial Growth Factor Receptor-1/metabolism
12.
Proc Natl Acad Sci U S A ; 100(14): 8292-7, 2003 Jul 08.
Article in English | MEDLINE | ID: mdl-12829789

ABSTRACT

To investigate the function of the Grb10 adapter protein, we have generated mice in which the Grb10 gene was disrupted by a gene-trap insertion. Our experiments confirm that Grb10 is subject to genomic imprinting with the majority of Grb10 expression arising from the maternally inherited allele. Consistent with this, disruption of the maternal allele results in overgrowth of both the embryo and placenta such that mutant mice are at birth approximately 30% larger than normal. This observation establishes that Grb10 is a potent growth inhibitor. In humans, GRB10 is located at chromosome 7p11.2-p12 and has been associated with Silver-Russell syndrome, in which approximately 10% of those affected inherit both copies of chromosome 7 from their mother. Our results indicate that changes in GRB10 dosage could, in at least some cases, account for the severe growth retardation that is characteristic of Silver-Russell syndrome. Because Grb10 is a signaling protein capable of interacting with tyrosine kinase receptors, we tested genetically whether Grb10 might act downstream of insulin-like growth factor 2, a paternally expressed growth-promoting gene. The result indicates that Grb10 action is essentially independent of insulin-like growth factor 2, providing evidence that imprinting acts on at least two major fetal growth axes in a manner consistent with parent-offspring conflict theory.


Subject(s)
Embryonic and Fetal Development/genetics , Fetal Macrosomia/genetics , Genomic Imprinting , Growth Inhibitors/physiology , Placenta/abnormalities , Proteins/physiology , Alleles , Alternative Splicing , Animals , Cell Line , Chimera , Crosses, Genetic , Female , GRB10 Adaptor Protein , Gene Dosage , Gene Targeting , Genes, Reporter , Genes, Synthetic , Growth Inhibitors/chemistry , Growth Inhibitors/deficiency , Growth Inhibitors/genetics , Insulin-Like Growth Factor II/physiology , Lac Operon , Liver/embryology , Liver/pathology , Lung/abnormalities , Lung/embryology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Models, Biological , Organ Specificity , Proteins/chemistry , Proteins/genetics , RNA, Messenger/biosynthesis , Sequence Deletion , Signal Transduction , Stem Cells/cytology
SELECTION OF CITATIONS
SEARCH DETAIL